Compare ES & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ES | GEHC |
|---|---|---|
| Founded | 1927 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Computer Software: Prepackaged Software |
| Sector | Utilities | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.2B | 29.9B |
| IPO Year | 1994 | 2022 |
| Metric | ES | GEHC |
|---|---|---|
| Price | $72.15 | $64.64 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 13 |
| Target Price | $71.00 | ★ $88.38 |
| AVG Volume (30 Days) | 2.8M | ★ 4.3M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.58% | 0.24% |
| EPS Growth | ★ 100.88 | 4.84 |
| EPS | ★ 1.61 | 0.85 |
| Revenue | $13,547,244,000.00 | ★ $20,625,000,000.00 |
| Revenue This Year | N/A | $7.12 |
| Revenue Next Year | $3.77 | $4.45 |
| P/E Ratio | ★ $44.93 | $75.41 |
| Revenue Growth | ★ 13.83 | 4.84 |
| 52 Week Low | $61.53 | $58.75 |
| 52 Week High | $76.41 | $89.77 |
| Indicator | ES | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 59.43 | 52.33 |
| Support Level | $66.36 | $60.08 |
| Resistance Level | $74.79 | $65.47 |
| Average True Range (ATR) | 1.29 | 1.81 |
| MACD | 0.32 | 0.24 |
| Stochastic Oscillator | 76.59 | 73.11 |
Eversource Energy is a diversified holding company with subsidiaries that provide rate-regulated electric, gas, and water distribution service to more than 4 million customers in the Northeast US. Eversource expanded its service territories with acquisitions of NStar (2012), Aquarion (2017), and Columbia Gas (2020). In 2024 Eversource exited its 50% partnership with European utility Orsted to develop 2 gigawatts of offshore wind projects in the Northeast US. It plans to sell Aquarion in 2026. The company exited most of its unregulated businesses in 2006.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).